Cencora distributes pharmaceuticals and healthcare products across the United States and internationally. Its U.S. segment supplies generic and specialty drugs, medical equipment, and vaccines to hospitals, pharmacies, clinics, and other healthcare providers, while also offering pharmacy consulting, software, and data analytics services; it additionally distributes animal health products and provides commercialization support for pharmaceutical manufacturers. The International segment operates pharmaceutical wholesale operations and logistics services for biopharmaceutical companies across global markets.
1Y: 309.41 (+7.2%) · range 251.67–372.53
entry readiness 16 · NOT READY · exit proximity 0
Value area 272.26–333.01 · 37% of 120d volume overhead · moderate overhead
| Source | Score | Last seen |
|---|---|---|
| earnings-surprise | 0.006 | Sep 3, 2026 |
| Horizon | Return | MFE | State |
|---|---|---|---|
| 20d | +8.26% | +10.80% | mature |
| 40d | +11.59% | +15.76% | mature |